NYSE: CPTCamden Property Trust Stock
$110.81-1.47 (-1.31%)
Updated Apr 21, 2025
CPT Price
$110.81
Fair Value Price
N/A
Market Cap
$11.83B
52 Week Low
$97.12
52 Week High
$127.69
P/E
73.87x
P/B
2.53x
P/S
8.03x
PEG
1.05x
Dividend Yield
2.81%
Revenue
$1.57B
Earnings
$163.29M
Gross Margin
61.8%
Operating Margin
18.88%
Profit Margin
10.4%
Debt to Equity
0.88
Operating Cash Flow
$775M
Beta
0.69
Next Earnings
Apr 30, 2025
Ex-Dividend
N/A
Next Dividend
N/A
CPT Overview
Camden Property Trust is a Real Estate Investment Trust (REIT) that invests in apartments in the U.S. Its portfolio is primarily located in the Sun Belt, Houston, Dallas, Las Vegas, and Atlanta. The company was founded in 1981 and is headquartered in Houston, TX.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CPT's potential to beat the market
DSell
- Stocks with a Zen Rating of Sell (D) had an average loss of -4.50% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Industry: Residential REIT
Industry Rating
F
CPT
Ranked#15 of 20
Ranked#15 of 20
Top Ranked Stocks in Industry
| Name / Ticker | Price | Zen Rating |
|---|---|---|
| $64.43 | C | |
| $7.62 | C | |
| $23.52 | C |
Be the first to know about important CPT news, forecast changes, insider trades & much more!
CPT News
Overview
Due Diligence Score
–
Industry Average (26)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CPT scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CPT ($110.81) is trading above its intrinsic value of $44.71, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CPT is poor value based on its earnings relative to its share price (73.87x), compared to the US market average (27.14x)
P/E vs Market Valuation
CPT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CPT due diligence checks available for Premium users.
Valuation
CPT price to earnings (PE)
For valuing profitable companies with steady earnings
Company
73.87x
Industry
60.45x
Market
27.14x
CPT is poor value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CPT is poor value based... subscribe to Premium to read more.
P/E vs Market Valuation
CPT price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.53x
Industry
2.36x
CPT is poor value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CPT price to earnings growth (PEG)
For valuing profitable companies with growth potential
CPT is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CPT's financial health
Profit margin
Revenue
$385.3M
Net Income
$40.7M
Profit Margin
10.6%
CPT's Earnings (EBIT) of $296.03M... subscribe to Premium to read more.
Interest Coverage Financials
CPT's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$8.9B
Liabilities
$4.1B
Debt to equity
0.88
CPT's debt has increased relative... subscribe to Premium to read more.
Shrinking Debt Financials
CPT's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$152.4M
Investing
-$89.2M
Financing
-$73.3M
CPT's operating cash flow ($774.88M)... subscribe to Premium to read more.
Debt Coverage Financials
CPT vs Residential REIT Stocks
Camden Property Trust Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.